🔴 Alzamend Neuro is trading 7.6% down in after-hours trading with no clear catalyst identified

Alzamend Neuro is trading 7.6% down at $1.46, with no clear company-specific catalyst identified for the after-hours decline.

• Fell from the regular-session close of $1.58 on August 17, 2026.
• Recent coverage centers on the previously announced $7.5 million financing.
• Major U.S. indexes also ended modestly lower.